Cargando…

Hepatic necrosis associated with drug-induced hypersensitivity syndrome

Drug-induced hypersensitivity syndrome (DIHS; also known as drug reaction with eosinophilia and systemic symptoms [DRESS]) is a life-threatening condition first described by Chaiken et al. in 1950. It is characterized by extensive mucocutaneous rash; fever; lymphadenopathy; hepatitis; hematological...

Descripción completa

Detalles Bibliográficos
Autores principales: de Campos, Fernando Peixoto Ferraz, de Lima, Patricia Picciarelli, Maragno, Luciana, Watanabe, Fabio Toshio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: São Paulo, SP: Universidade de São Paulo, Hospital Universitário 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6735577/
https://www.ncbi.nlm.nih.gov/pubmed/31528583
http://dx.doi.org/10.4322/acr.2012.029
_version_ 1783450378674634752
author de Campos, Fernando Peixoto Ferraz
de Lima, Patricia Picciarelli
Maragno, Luciana
Watanabe, Fabio Toshio
author_facet de Campos, Fernando Peixoto Ferraz
de Lima, Patricia Picciarelli
Maragno, Luciana
Watanabe, Fabio Toshio
author_sort de Campos, Fernando Peixoto Ferraz
collection PubMed
description Drug-induced hypersensitivity syndrome (DIHS; also known as drug reaction with eosinophilia and systemic symptoms [DRESS]) is a life-threatening condition first described by Chaiken et al. in 1950. It is characterized by extensive mucocutaneous rash; fever; lymphadenopathy; hepatitis; hematological abnormalities; damage to several organs such as kidney, heart, lungs, and pancreas; and possible reactivation of human herpesvirus-6 (HHV-6) or other herpes virus. Rare and severe cases may present hepatic necrosis, and about 15% of them result in death or liver transplantation. A hallmark of this syndrome is the late onset of symptoms after the drug exposure. The most common culprit drugs are the aromatic anticonvulsants (in almost 30% of the cases) and the antibiotics (which in some series represent 20% of the cases). The authors report a case of a 41-year-old female who presented to the emergency department with erythroderma, acute hepatitis, acute pancreatitis and acute renal failure, and was then treated with corticosteroid after the diagnosis of DIHS/DRESS. A specific culprit drug could not confidently be determined due to the presence of multiple drugs used by the patient. The clinical and laboratory outcome was apparently satisfactory, but unexpectedly, on the sixth day of hospitalization, the patient complained of nonspecific malaise, drowsiness, which progressed in a few hours with signs and symptoms of hepatic failure, refractory shock, and death. The autopsy findings showed submassive hepatic necrosis, and the immediate cause of death was attributed to hepatic failure.
format Online
Article
Text
id pubmed-6735577
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher São Paulo, SP: Universidade de São Paulo, Hospital Universitário
record_format MEDLINE/PubMed
spelling pubmed-67355772019-09-16 Hepatic necrosis associated with drug-induced hypersensitivity syndrome de Campos, Fernando Peixoto Ferraz de Lima, Patricia Picciarelli Maragno, Luciana Watanabe, Fabio Toshio Autops Case Rep Article / Autopsy Case Report Drug-induced hypersensitivity syndrome (DIHS; also known as drug reaction with eosinophilia and systemic symptoms [DRESS]) is a life-threatening condition first described by Chaiken et al. in 1950. It is characterized by extensive mucocutaneous rash; fever; lymphadenopathy; hepatitis; hematological abnormalities; damage to several organs such as kidney, heart, lungs, and pancreas; and possible reactivation of human herpesvirus-6 (HHV-6) or other herpes virus. Rare and severe cases may present hepatic necrosis, and about 15% of them result in death or liver transplantation. A hallmark of this syndrome is the late onset of symptoms after the drug exposure. The most common culprit drugs are the aromatic anticonvulsants (in almost 30% of the cases) and the antibiotics (which in some series represent 20% of the cases). The authors report a case of a 41-year-old female who presented to the emergency department with erythroderma, acute hepatitis, acute pancreatitis and acute renal failure, and was then treated with corticosteroid after the diagnosis of DIHS/DRESS. A specific culprit drug could not confidently be determined due to the presence of multiple drugs used by the patient. The clinical and laboratory outcome was apparently satisfactory, but unexpectedly, on the sixth day of hospitalization, the patient complained of nonspecific malaise, drowsiness, which progressed in a few hours with signs and symptoms of hepatic failure, refractory shock, and death. The autopsy findings showed submassive hepatic necrosis, and the immediate cause of death was attributed to hepatic failure. São Paulo, SP: Universidade de São Paulo, Hospital Universitário 2012-12-31 /pmc/articles/PMC6735577/ /pubmed/31528583 http://dx.doi.org/10.4322/acr.2012.029 Text en Copyright © 2012 Autopsy and Case Reports http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed of terms of the Creative Commons Attribution Non-Commercial License which permits unrestricted non-commercial use, distribution, and reproduction in any médium provided article is properly cited.
spellingShingle Article / Autopsy Case Report
de Campos, Fernando Peixoto Ferraz
de Lima, Patricia Picciarelli
Maragno, Luciana
Watanabe, Fabio Toshio
Hepatic necrosis associated with drug-induced hypersensitivity syndrome
title Hepatic necrosis associated with drug-induced hypersensitivity syndrome
title_full Hepatic necrosis associated with drug-induced hypersensitivity syndrome
title_fullStr Hepatic necrosis associated with drug-induced hypersensitivity syndrome
title_full_unstemmed Hepatic necrosis associated with drug-induced hypersensitivity syndrome
title_short Hepatic necrosis associated with drug-induced hypersensitivity syndrome
title_sort hepatic necrosis associated with drug-induced hypersensitivity syndrome
topic Article / Autopsy Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6735577/
https://www.ncbi.nlm.nih.gov/pubmed/31528583
http://dx.doi.org/10.4322/acr.2012.029
work_keys_str_mv AT decamposfernandopeixotoferraz hepaticnecrosisassociatedwithdruginducedhypersensitivitysyndrome
AT delimapatriciapicciarelli hepaticnecrosisassociatedwithdruginducedhypersensitivitysyndrome
AT maragnoluciana hepaticnecrosisassociatedwithdruginducedhypersensitivitysyndrome
AT watanabefabiotoshio hepaticnecrosisassociatedwithdruginducedhypersensitivitysyndrome